Perspectives

In this paper we highlight several key themes and recommendations that are essential to consider when navigating our new market environment post COVID-19.

Perhaps more so than any other modality to date, cancer cell therapies have captured the imaginations and wherewithal of industry, investor, and oncologist communities alike...

You will have likely seen recently that inappropriate use of Microsoft Excel® has led to a major issue with the UK’s Test and Trace system, with the reporting of almost 16,000 positive COVID-19 cases being delayed for over a week due to CSV row number limitations.1 The heart of the issue is the use of Excel to transfer data between one system and another – and, more generally, continuing to use outdated software versions and antiquated methods to transfer data, rather than creating systems that truly talk to each other and operate within the same framework (i.e. that are capable of record storage as well as the powerful analytical analysis required to perform country-wide pandemic modelling).

October is Health Literacy Month, and if current events this year have proven anything, it is that health literacy is more important than ever. Before discussing the timely circumstances, let us first backtrack for a moment and understand this concept. Health literacy can be defined as an individual’s ability to comprehend and communicate basic health information. Recently however, the definition has been expanded to include both personal health literacy and organizational health literacy. Personal health literacy is the extent to which an individual understands health related information, which informs their actions. As for organizational health literacy, this is the extent an organization provides individuals with health-related information, so they can make educated decisions about their health. Therefore, these two pieces of health literacy are intrinsically tied to each other.